Sign up Australia
Proactive Investors - Run By Investors For Investors

Queensland Bauxite gets results from winter cannabis crop

Potential market updates are expected regarding production, marketing and distribution agreements
Cannabis plants
Shares have doubled in 2017 to $0.011

Queensland Bauxite Ltd (ASX:QBL), through its subsidiary Medical Cannabis Limited (MCL) has received a successful update regarding its winter cannabis crops.

This follows on from the early-July update that confirmed successful germination and growth rates of its pioneering winter cannabis crop.

There have been very few serious winter trials in Australia and information as to the success of these trials is scarce and uninformative.

MCL began a winter growth of cannabis so as to be ready for production as soon as hemp food becomes legal in Australia at the end of this year.

READ: Queensland Bauxite aims for early mining at South Johnstone project

Positioning itself to be the dominant producer

The company is actively negotiating production, marketing and distribution agreements and market updates can be expected once these are finalised.

MCL is well positioned to be the dominant producer of Australian-grown and produced hemp food products.

Medical cannabis research program

The company is also significantly progressing its medical cannabis research and development programme.

It has been assessing various world class strategic relationships to ensure maximum value and productivity from its cutting edge work plan.

The work plan includes:

- Research into the unique cultivars and seed bank that the company owns to maximise its market value; and
- utilising cutting edge technology and research to create legal, consistent and approved medical cannabis products in the relative short term.

View full QBL profile View Profile

Queensland Bauxite Ltd Timeline

Related Articles

Pantoro processing plant
April 04 2018
The company's AISC for the December quarter 2017 was $990 per ounce.
Rare Earths
January 25 2018
The AIM listed firm said Talaxis has invested £5mln (C$8.8mln) into Lancaster Exploration Limited - the subsidiary which holds the licence for the advanced stage Songwe Hill rare earths project in Malawi - in return for a 20% interest in the business
Drilling at Coglia Well
May 10 2018
Pending exploration results combined with those from a second drill program should allow the company to establish a resource estimate.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use